Efficacy of Internet-Based Cognitive Behavioral Therapy for Treatment-Induced Menopausal Symptoms in Breast Cancer Survivors: Results of a Randomized Controlled Trial.


Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333

Informations de publication

Date de publication:
01 04 2019
Historique:
pubmed: 15 2 2019
medline: 25 2 2020
entrez: 15 2 2019
Statut: ppublish

Résumé

We evaluated the effect of Internet-based cognitive behavioral therapy (iCBT), with or without therapist support, on the perceived impact of hot flushes and night sweats (HF/NS) and overall levels of menopausal symptoms (primary outcomes), sleep quality, HF/NS frequency, sexual functioning, psychological distress, and health-related quality of life in breast cancer survivors with treatment-induced menopausal symptoms. We randomly assigned 254 breast cancer survivors to a therapist-guided or a self-managed iCBT group or to a waiting list control group. The 6-week iCBT program included psycho-education, behavior monitoring, and cognitive restructuring. Questionnaires were administered at baseline and at 10 weeks and 24 weeks postrandomization. We used mixed-effects models to compare the intervention groups with the control group over time. Significance was set at P < .01. An effect size (ES) of .20 was considered small, .50 moderate and clinically significant, and .80 large. Compared with the control group, the guided and self-managed iCBT groups reported a significant decrease in the perceived impact of HF/NS (ES, .63 and .56, respectively; both P < .001) and improvement in sleep quality (ES, .57 and .41; both P < .001). The guided group also reported significant improvement in overall levels of menopausal symptoms (ES, .33; P = .003), and NS frequency (ES, .64; P < .001). At longer-term follow-up (24 weeks), the effects remained significant, with a smaller ES for the guided group on perceived impact of HF/NS and sleep quality and for the self-managed group on overall levels of menopausal symptoms. Additional longer-term effects for both intervention groups were found for hot flush frequency. iCBT, with or without therapist support, has clinically significant, salutary effects on the perceived impact and frequency of HF/NS, overall levels of menopausal symptoms, and sleep quality.

Identifiants

pubmed: 30763176
doi: 10.1200/JCO.18.00655
doi:

Banques de données

ClinicalTrials.gov
['NCT02672189']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

809-822

Auteurs

Vera Atema (V)

1 The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Marieke van Leeuwen (M)

1 The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Jacobien M Kieffer (JM)

1 The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Hester S A Oldenburg (HSA)

1 The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Marc van Beurden (M)

1 The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Miranda A Gerritsma (MA)

1 The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Marianne A Kuenen (MA)

1 The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Peter W Plaisier (PW)

2 Albert Schweitzer Hospital, Dordrecht, the Netherlands.

Alexander M F Lopes Cardozo (AMF)

3 Noordwest Hospital Group Alkmaar, Alkmaar, the Netherlands.

Yvonne E A van Riet (YEA)

4 Catharina Hospital, Eindhoven, the Netherlands.

Gijsbert Heuff (G)

5 Spaarne Gasthuis Hoofddorp, Hoofddorp, the Netherlands.

Herman Rijna (H)

6 Spaarne Gasthuis Haarlem, Haarlem, the Netherlands.

Suzan van der Meij (S)

7 Flevo Hospital, Almere, the Netherlands.

Eva M Noorda (EM)

8 Isala Zwolle, Zwolle, the Netherlands.

Gert-Jan Timmers (GJ)

9 Hospital Amstelland, Amstelveen, the Netherlands.

Bart C Vrouenraets (BC)

10 Onze Lieve Vrouwe Gasthuis West, Amsterdam, the Netherlands.

Matthé Bollen (M)

11 Medical Centre Zuiderzee, Lelystad, the Netherlands.

Henk van der Veen (H)

12 Red Cross Hospital, Beverwijk, the Netherlands.

Nina Bijker (N)

13 Amsterdam UMC, Amsterdam, the Netherlands.

Myra S Hunter (MS)

14 Kings College London, London, United Kingdom.

Neil K Aaronson (NK)

1 The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH